1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Sleep-Wake Disorder Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Insomnia 1.2.3 Hypersomnia 1.2.4 Sleep Apnea 1.2.5 Circadian Rhythm Disorders 1.2.6 Others 1.3 Market by Treatment 1.3.1 Global Sleep-Wake Disorder Market Share by Treatment: 2017 VS 2021 VS 2028 1.3.2 Therapies 1.3.3 Medications 1.3.4 Devices 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Sleep-Wake Disorder Market Perspective (2017-2028) 2.2 Sleep-Wake Disorder Growth Trends by Region 2.2.1 Sleep-Wake Disorder Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Sleep-Wake Disorder Historic Market Size by Region (2017-2022) 2.2.3 Sleep-Wake Disorder Forecasted Market Size by Region (2023-2028) 2.3 Sleep-Wake Disorder Market Dynamics 2.3.1 Sleep-Wake Disorder Industry Trends 2.3.2 Sleep-Wake Disorder Market Drivers 2.3.3 Sleep-Wake Disorder Market Challenges 2.3.4 Sleep-Wake Disorder Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Sleep-Wake Disorder Players by Revenue 3.1.1 Global Top Sleep-Wake Disorder Players by Revenue (2017-2022) 3.1.2 Global Sleep-Wake Disorder Revenue Market Share by Players (2017-2022) 3.2 Global Sleep-Wake Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Sleep-Wake Disorder Revenue 3.4 Global Sleep-Wake Disorder Market Concentration Ratio 3.4.1 Global Sleep-Wake Disorder Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Sleep-Wake Disorder Revenue in 2021 3.5 Sleep-Wake Disorder Key Players Head office and Area Served 3.6 Key Players Sleep-Wake Disorder Product Solution and Service 3.7 Date of Enter into Sleep-Wake Disorder Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Sleep-Wake Disorder Breakdown Data by Type 4.1 Global Sleep-Wake Disorder Historic Market Size by Type (2017-2022) 4.2 Global Sleep-Wake Disorder Forecasted Market Size by Type (2023-2028) 5 Sleep-Wake Disorder Breakdown Data by Treatment 5.1 Global Sleep-Wake Disorder Historic Market Size by Treatment (2017-2022) 5.2 Global Sleep-Wake Disorder Forecasted Market Size by Treatment (2023-2028) 6 North America 6.1 North America Sleep-Wake Disorder Market Size (2017-2028) 6.2 North America Sleep-Wake Disorder Market Size by Country (2017-2022) 6.3 North America Sleep-Wake Disorder Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Sleep-Wake Disorder Market Size (2017-2028) 7.2 Europe Sleep-Wake Disorder Market Size by Country (2017-2022) 7.3 Europe Sleep-Wake Disorder Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Sleep-Wake Disorder Market Size (2017-2028) 8.2 Asia-Pacific Sleep-Wake Disorder Market Size by Country (2017-2022) 8.3 Asia-Pacific Sleep-Wake Disorder Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Sleep-Wake Disorder Market Size (2017-2028) 9.2 Latin America Sleep-Wake Disorder Market Size by Country (2017-2022) 9.3 Latin America Sleep-Wake Disorder Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Sleep-Wake Disorder Market Size (2017-2028) 10.2 Middle East & Africa Sleep-Wake Disorder Market Size by Country (2017-2022) 10.3 Middle East & Africa Sleep-Wake Disorder Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Jazz Pharmaceuticals 11.1.1 Jazz Pharmaceuticals Company Detail 11.1.2 Jazz Pharmaceuticals Business Overview 11.1.3 Jazz Pharmaceuticals Sleep-Wake Disorder Introduction 11.1.4 Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2017-2022) 11.1.5 Jazz Pharmaceuticals Recent Development 11.2 Koninklijke Philips N.V. 11.2.1 Koninklijke Philips N.V. Company Detail 11.2.2 Koninklijke Philips N.V. Business Overview 11.2.3 Koninklijke Philips N.V. Sleep-Wake Disorder Introduction 11.2.4 Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2017-2022) 11.2.5 Koninklijke Philips N.V. Recent Development 11.3 Merck KGaA 11.3.1 Merck KGaA Company Detail 11.3.2 Merck KGaA Business Overview 11.3.3 Merck KGaA Sleep-Wake Disorder Introduction 11.3.4 Merck KGaA Revenue in Sleep-Wake Disorder Business (2017-2022) 11.3.5 Merck KGaA Recent Development 11.4 Neurocrine Biosciences 11.4.1 Neurocrine Biosciences Company Detail 11.4.2 Neurocrine Biosciences Business Overview 11.4.3 Neurocrine Biosciences Sleep-Wake Disorder Introduction 11.4.4 Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2017-2022) 11.4.5 Neurocrine Biosciences Recent Development 11.5 RespireRx Pharmaceuticals Inc. 11.5.1 RespireRx Pharmaceuticals Inc. Company Detail 11.5.2 RespireRx Pharmaceuticals Inc. Business Overview 11.5.3 RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Introduction 11.5.4 RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2017-2022) 11.5.5 RespireRx Pharmaceuticals Inc. Recent Development 11.6 Medtronic PLC 11.6.1 Medtronic PLC Company Detail 11.6.2 Medtronic PLC Business Overview 11.6.3 Medtronic PLC Sleep-Wake Disorder Introduction 11.6.4 Medtronic PLC Revenue in Sleep-Wake Disorder Business (2017-2022) 11.6.5 Medtronic PLC Recent Development 11.7 Teva Pharmaceutical Industries Ltd. 11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail 11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview 11.7.3 Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Introduction 11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2017-2022) 11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development 11.8 Vanda Pharmaceuticals Inc. 11.8.1 Vanda Pharmaceuticals Inc. Company Detail 11.8.2 Vanda Pharmaceuticals Inc. Business Overview 11.8.3 Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Introduction 11.8.4 Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2017-2022) 11.8.5 Vanda Pharmaceuticals Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Sleep-Wake Disorder Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Insomnia Table 3. Key Players of Hypersomnia Table 4. Key Players of Sleep Apnea Table 5. Key Players of Circadian Rhythm Disorders Table 6. Key Players of Others Table 7. Global Sleep-Wake Disorder Market Size Growth by Treatment (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Sleep-Wake Disorder Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Sleep-Wake Disorder Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Sleep-Wake Disorder Market Share by Region (2017-2022) Table 11. Global Sleep-Wake Disorder Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Sleep-Wake Disorder Market Share by Region (2023-2028) Table 13. Sleep-Wake Disorder Market Trends Table 14. Sleep-Wake Disorder Market Drivers Table 15. Sleep-Wake Disorder Market Challenges Table 16. Sleep-Wake Disorder Market Restraints Table 17. Global Sleep-Wake Disorder Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Sleep-Wake Disorder Market Share by Players (2017-2022) Table 19. Global Top Sleep-Wake Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep-Wake Disorder as of 2021) Table 20. Ranking of Global Top Sleep-Wake Disorder Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Sleep-Wake Disorder Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Sleep-Wake Disorder Product Solution and Service Table 24. Date of Enter into Sleep-Wake Disorder Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Sleep-Wake Disorder Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Sleep-Wake Disorder Revenue Market Share by Type (2017-2022) Table 28. Global Sleep-Wake Disorder Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Sleep-Wake Disorder Revenue Market Share by Type (2023-2028) Table 30. Global Sleep-Wake Disorder Market Size by Treatment (2017-2022) & (US$ Million) Table 31. Global Sleep-Wake Disorder Revenue Market Share by Treatment (2017-2022) Table 32. Global Sleep-Wake Disorder Forecasted Market Size by Treatment (2023-2028) & (US$ Million) Table 33. Global Sleep-Wake Disorder Revenue Market Share by Treatment (2023-2028) Table 34. North America Sleep-Wake Disorder Market Size by Country (2017-2022) & (US$ Million) Table 35. North America Sleep-Wake Disorder Market Size by Country (2023-2028) & (US$ Million) Table 36. Europe Sleep-Wake Disorder Market Size by Country (2017-2022) & (US$ Million) Table 37. Europe Sleep-Wake Disorder Market Size by Country (2023-2028) & (US$ Million) Table 38. Asia-Pacific Sleep-Wake Disorder Market Size by Region (2017-2022) & (US$ Million) Table 39. Asia-Pacific Sleep-Wake Disorder Market Size by Region (2023-2028) & (US$ Million) Table 40. Latin America Sleep-Wake Disorder Market Size by Country (2017-2022) & (US$ Million) Table 41. Latin America Sleep-Wake Disorder Market Size by Country (2023-2028) & (US$ Million) Table 42. Middle East & Africa Sleep-Wake Disorder Market Size by Country (2017-2022) & (US$ Million) Table 43. Middle East & Africa Sleep-Wake Disorder Market Size by Country (2023-2028) & (US$ Million) Table 44. Jazz Pharmaceuticals Company Detail Table 45. Jazz Pharmaceuticals Business Overview Table 46. Jazz Pharmaceuticals Sleep-Wake Disorder Product Table 47. Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2017-2022) & (US$ Million) Table 48. Jazz Pharmaceuticals Recent Development Table 49. Koninklijke Philips N.V. Company Detail Table 50. Koninklijke Philips N.V. Business Overview Table 51. Koninklijke Philips N.V. Sleep-Wake Disorder Product Table 52. Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2017-2022) & (US$ Million) Table 53. Koninklijke Philips N.V. Recent Development Table 54. Merck KGaA Company Detail Table 55. Merck KGaA Business Overview Table 56. Merck KGaA Sleep-Wake Disorder Product Table 57. Merck KGaA Revenue in Sleep-Wake Disorder Business (2017-2022) & (US$ Million) Table 58. Merck KGaA Recent Development Table 59. Neurocrine Biosciences Company Detail Table 60. Neurocrine Biosciences Business Overview Table 61. Neurocrine Biosciences Sleep-Wake Disorder Product Table 62. Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2017-2022) & (US$ Million) Table 63. Neurocrine Biosciences Recent Development Table 64. RespireRx Pharmaceuticals Inc. Company Detail Table 65. RespireRx Pharmaceuticals Inc. Business Overview Table 66. RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Product Table 67. RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2017-2022) & (US$ Million) Table 68. RespireRx Pharmaceuticals Inc. Recent Development Table 69. Medtronic PLC Company Detail Table 70. Medtronic PLC Business Overview Table 71. Medtronic PLC Sleep-Wake Disorder Product Table 72. Medtronic PLC Revenue in Sleep-Wake Disorder Business (2017-2022) & (US$ Million) Table 73. Medtronic PLC Recent Development Table 74. Teva Pharmaceutical Industries Ltd. Company Detail Table 75. Teva Pharmaceutical Industries Ltd. Business Overview Table 76. Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Product Table 77. Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2017-2022) & (US$ Million) Table 78. Teva Pharmaceutical Industries Ltd. Recent Development Table 79. Vanda Pharmaceuticals Inc. Company Detail Table 80. Vanda Pharmaceuticals Inc. Business Overview Table 81. Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Product Table 82. Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2017-2022) & (US$ Million) Table 83. Vanda Pharmaceuticals Inc. Recent Development Table 84. Research Programs/Design for This Report Table 85. Key Data Information from Secondary Sources Table 86. Key Data Information from Primary Sources List of Figures Figure 1. Global Sleep-Wake Disorder Market Share by Type: 2021 VS 2028 Figure 2. Insomnia Features Figure 3. Hypersomnia Features Figure 4. Sleep Apnea Features Figure 5. Circadian Rhythm Disorders Features Figure 6. Others Features Figure 7. Global Sleep-Wake Disorder Market Share by Treatment in 2021 & 2028 Figure 8. Therapies Case Studies Figure 9. Medications Case Studies Figure 10. Devices Case Studies Figure 11. Sleep-Wake Disorder Report Years Considered Figure 12. Global Sleep-Wake Disorder Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Sleep-Wake Disorder Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Sleep-Wake Disorder Market Share by Region: 2021 VS 2028 Figure 15. Global Sleep-Wake Disorder Market Share by Players in 2021 Figure 16. Global Top Sleep-Wake Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep-Wake Disorder as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Sleep-Wake Disorder Revenue in 2021 Figure 18. North America Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Sleep-Wake Disorder Market Share by Country (2017-2028) Figure 20. United States Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Sleep-Wake Disorder Market Share by Country (2017-2028) Figure 24. Germany Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Sleep-Wake Disorder Market Share by Region (2017-2028) Figure 32. China Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Sleep-Wake Disorder Market Share by Country (2017-2028) Figure 40. Mexico Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Sleep-Wake Disorder Market Share by Country (2017-2028) Figure 44. Turkey Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Sleep-Wake Disorder Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Jazz Pharmaceuticals Revenue Growth Rate in Sleep-Wake Disorder Business (2017-2022) Figure 47. Koninklijke Philips N.V. Revenue Growth Rate in Sleep-Wake Disorder Business (2017-2022) Figure 48. Merck KGaA Revenue Growth Rate in Sleep-Wake Disorder Business (2017-2022) Figure 49. Neurocrine Biosciences Revenue Growth Rate in Sleep-Wake Disorder Business (2017-2022) Figure 50. RespireRx Pharmaceuticals Inc. Revenue Growth Rate in Sleep-Wake Disorder Business (2017-2022) Figure 51. Medtronic PLC Revenue Growth Rate in Sleep-Wake Disorder Business (2017-2022) Figure 52. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Sleep-Wake Disorder Business (2017-2022) Figure 53. Vanda Pharmaceuticals Inc. Revenue Growth Rate in Sleep-Wake Disorder Business (2017-2022) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed